Outcomes of rituximab as treatment for immune thrombocytopenic purpura in patients who have failed steroids or IVIG: A retrospective study in a community practice. This is an ASCO Meeting Abstract ...
The researchers stated that their HRQOL questionnaire “holds promise as a reliable and valid tool for use in both clinical trials and practice.” A specially designed, age-appropriate, cross-cultural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results